Pfizer/BioNTech to submit COVID vaccine for approval as latest data show it to be 95% effective

Pfizer and BioNTech plan to submit their COVID-19 vaccine for approval 'within days' after latest data from its phase 3 trial showed it to be 95% effective at preventing the coronavirus.

by Emma Bower
(Photo: Justin Tallis/Getty Images)
(Photo: Justin Tallis/Getty Images)

Sign in to continue

Sign In

Trouble signing in?

Reset password: Click here

Need help? Email us

Register

FREE

  • Limited free articles a month 
  • Free email bulletins

Register Now Register Now

Take a 30-day trial

  • Join MIMS now and pay nothing for the first 30 days
  • Join GPOnline now and pay nothing for the first 30 days

Sign Up Sign Up